| Patricia Gwen Dominguez, RADT | |
|
310 Harris Ave Ste A, Sacramento, CA 95838-3249 | |
| (916) 649-6793 | |
| (916) 929-7411 |
| Full Name | Patricia Gwen Dominguez |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 310 Harris Ave Ste A, Sacramento, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043886054 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Gwen Dominguez, RADT 310 Harris Ave Ste A310, Sacramento, CA 95838-3249 Ph: (916) 649-6793 | Patricia Gwen Dominguez, RADT 310 Harris Ave Ste A, Sacramento, CA 95838-3249 Ph: (916) 649-6793 |
News Archive
A dual-acting osteoporosis drug. Minimally invasive mitral valve surgery. New treatment for peanut allergies. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of doctors and researchers.
Observing surfers with cystic fibrosis (CF) led scientists to discover that the inhaled mist of seawater has a therapeutic effect on the lung problems associated with the disease. Now the findings have been used by pharmaceutical company Parion Sciences and product development firm Cambridge Consultants in a revolutionary new aerosol delivery system. It enables CF sufferers to get the benefits of saltwater treatment in their own homes overnight while they sleep.
When the pro-inflammatory pair, a receptor called CCR2 and its ligand CCL-2, get together, it increases the risk of developing type 1 diabetes, scientists report.
According to an advisory panel to the U.S. Food and Drug Administration, genetic tests sold directly to consumers that might help to predict health risks may need to be supplied through doctors. An official, Alberto Gutierrez, director of the FDA office that regulates diagnostic screening tools reported that the Molecular and Clinical Genetics Advisory Panel concluded two days of hearings on the increasingly popular tests and had come to this resolution.
As the number of children with severe COVID-19 illness grows, there is increasing urgency to ensure that potential treatments and vaccines are tested for safety and efficacy in children.
› Verified 7 days ago